
Tirzepatide · 10 mg
"Metabolic freedom, achieved."
Tirzepatide (LY3298176) is a novel once-weekly synthetic peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual incretin mechanism produces complementary and synergistic effects on insulin secretion, glucagon suppression, gastric emptying, and central appetite regulation. Preclinical and clinical studies have demonstrated significant reductions in body weight and improvements in glycaemic control, positioning it as one of the most compelling compounds in metabolic research today.
Research Focus Areas
Our pre-filled pens eliminate the steps that stand between you and your protocol. No bacteriostatic water, no syringes, no reconstitution calculations. Just consistent, precise delivery from day one.

Every BioPepTech pen is presented in our handcrafted signature case, designed to protect it during travel and reflect the precision inside. A protocol worth doing is worth keeping well.
Message us on WhatsApp. Our team will confirm availability, dosing guidance, and arrange Bali delivery.